Cancer-associated fibroblasts as targets for immunotherapy

Related Experiment Video

Updated: May 16, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

Sunitha Kakarla1, Xiao-Tong Song, Stephen Gottschalk

  • 1Center for Cell & Gene Therapy, Texas Children's Hospital, The Methodist Hospital, Baylor College of Medicine, 1102 Bates Street, Suite 1770, Houston, TX 77030, USA.

Immunotherapy
|December 1, 2012
PubMed

Insights

Targeting cancer-associated fibroblasts (CAFs) may enhance immunotherapy for solid tumors. Understanding the cross-talk between CAFs and cancer cells is key to overcoming treatment limitations and preventing recurrence.

Area of Science:

  • Oncology
  • Cancer Immunology
  • Tumor Microenvironment

Background:

  • Immunotherapy shows promise for solid tumors but has limited efficacy.
  • Solid tumor complexity and microenvironment hinder long-lasting therapeutic responses.
  • Tumor-directed therapies often fail to eliminate microenvironment components, leading to recurrence.

Purpose of the Study:

  • To highlight the cross-talk between cancer-associated fibroblasts (CAFs) and cancer cells.
  • To discuss the potential of targeting CAFs to improve cancer immunotherapy.

Main Methods:

  • Review of preclinical and clinical studies on immunotherapy for solid tumors.
  • Analysis of the role of cancer-associated fibroblasts (CAFs) in the tumor microenvironment.
  • Exploration of the communication pathways between CAFs and cancer cells.

Main Results:

  • Cancer-associated fibroblasts (CAFs) are the most abundant cells in the solid tumor microenvironment.
  • CAFs play a significant role in promoting tumor growth and metastasis.
  • Targeting CAFs presents a promising strategy to enhance immunotherapy efficacy.

Conclusions:

  • Targeting cancer-associated fibroblasts (CAFs) can potentially overcome limitations in current immunotherapy for solid tumors.
  • Understanding CAF-cancer cell interactions is crucial for developing effective therapeutic strategies.
  • Modulating the tumor microenvironment by targeting CAFs may lead to improved and durable anti-cancer responses.

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...